article thumbnail

A Forthcoming Shift of Pharmaceutical Sales Compensation Plans?

OpenSymmetry

Sales in the pharmaceutical industry has been a rigid and consistent business. However, a recent article from the Harvard Business Review suggests the stagnant methods of pharmaceutical sales rep compensation may be the root cause of an even bigger public health issue. Share your thoughts in the comments below!

article thumbnail

A Forthcoming Shift of Pharmaceutical Sales Compensation Plans?

OpenSymmetry

Sales in the pharmaceutical industry has been a rigid and consistent business. However, a recent article from the Harvard Business Review suggests the stagnant methods of pharmaceutical sales rep compensation may be the root cause of an even bigger public health issue. Share your thoughts in the comments below!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Major Accounts – The Growth Framework

Pipeliner

Recently, I had a planning session with a CSO from an HR services firm that had just landed their first large client, a Fortune 500 pharmaceutical company. The dreaded hand-off is simply unworkable with enterprise accounts. In enterprise accounts, decision-makers come and go, as our CSO’s pharmaceutical success story shows.

Account 98
article thumbnail

@Qstream Achieves 30% New Business Revenue Growth in 2020

SBI

This momentum speaks to significant market demand in corporate enterprises seeking remote learning technology to better engage distributed teams and providing them with learning and development opportunities. Qstream also announced these remarkable milestones: 458% year over year increase in the number of learners on the platform.

Revenue 98
article thumbnail

2021 Job Market: Watch for Funding, Flexibility, and Diversity

Zoominfo

Other industries with strong funding in 2020 included the pharmaceutical and energy fields. If you like the feeling when a company moves quickly and releases plenty of new products, smaller-sized and enterprise-level companies are a good bet. Want to work for an innovative company?

Nonprofit 246
article thumbnail

Can AI Deliver the 'Glengarry' Leads?

Sales and Marketing Management

Martin worked as a field rep with Pfizer Pharmaceuticals before making the transition to enterprise software sales, business consulting, and launching two start-ups in healthcare. He joined Conversica in 2014, where he has helped sell and lead triple digit growth for three consecutive years in a row since 2015.

article thumbnail

Who Is Your Customer?

Partners in Excellence

We aren’t a healthcare company and don’t buy medical devices/pharmaceutical products. We aren’t interested in the enterprise wide products the large consulting and professional services firms use. We don’t deal in commodity buying/selling. We are a specialized boutique consulting company.